Among potential prognostic indicators, the Ki67 index has garnered attention as a key marker of tumor cell proliferation, making it a strong candidate for assessing survival and recurrence patterns in NAC-treated patients with breast cancer. This evidence concerns the gene MKI67 and breast cancer.